Global AI-based Retinal Screening System Market to Reach USD 2.74 Billion by 2031, Driven by Rapid Adoption of AI in Ophthalmology

Los Angeles, CA - May 2025 - QYResearch, a global market intelligence leader, has released its latest report titled "Global AI-based Retinal Screening System Market Research Report 2025," revealing that the market is set to grow from USD 1.2 billion in 2024 to USD 2.74 billion by 2031, expanding at a strong CAGR of 12.5% during the forecast period.

The increasing global burden of vision-threatening diseases, including diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma, has intensified the demand for early detection tools. AI-powered retinal screening systems are emerging as a game-changing technology, enabling scalable, fast, and accurate diagnosis in both clinical and remote settings.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/service-software-global-ai-based-retinal-screening-system-market-research-report-2025

Market Drivers

1. Rising Prevalence of Diabetes and Eye Disorders: With diabetes affecting over 500 million people globally, the need for routine retinal screening has grown exponentially.

2. Advances in AI and Deep Learning Technologies: Machine learning models have achieved high sensitivity and specificity, making them reliable for large-scale screening.

3. Expansion of Telemedicine and Point-of-Care Screening: The integration of AI systems in portable devices allows rural and underserved populations access to ophthalmic care.

Future Outlook

As healthcare systems embrace preventive care and automation, AI-based retinal screening systems are poised to become an essential part of vision health management globally. Market players that focus on regulatory compliance, interoperability, and user-friendly AI interfaces will gain a significant competitive edge.

Details of AI-based Retinal Screening System Market Segmentation: -

Segment by Key Manufacturers:

McKinsey & Company
Deloitte
PwC
Control Risks
SAS
IBM
Risk Management Solutions
Verisk Analytics
S&P Global Risk Solutions
Cirium Ascend Consultancy
SGS
EY

Segment by Type

Preventive Assessment
Dynamic Assessment During The Event
Post-Event Review and Assessment

Segment by Application

SMEs
Large Enterprise

Regional Highlights

North America and Asia-Pacific are dominating the market, with Asia-Pacific expected to register the fastest growth due to rising healthcare investments, increasing awareness of preventable blindness, and favorable government initiatives in digital health.

Unlock Exclusive Market Insights - Customize Your Research Report Now! https://www.qyresearch.in/pre-order-inquiry/service-software-global-ai-based-retinal-screening-system-market-research-report-2025

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Retinal Screening System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud-based
1.2.3 On-premises
1.3 Market by Application
1.3.1 Global AI-based Retinal Screening System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetic Retinopathy
1.3.3 Age-related Macular Degeneration
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global AI-based Retinal Screening System Market Perspective (2020-2031)
2.2 Global AI-based Retinal Screening System Growth Trends by Region
2.2.1 Global AI-based Retinal Screening System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI-based Retinal Screening System Historic Market Size by Region (2020-2025)
2.2.3 AI-based Retinal Screening System Forecasted Market Size by Region (2026-2031)
2.3 AI-based Retinal Screening System Market Dynamics
2.3.1 AI-based Retinal Screening System Industry Trends
2.3.2 AI-based Retinal Screening System Market Drivers
2.3.3 AI-based Retinal Screening System Market Challenges
2.3.4 AI-based Retinal Screening System Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top AI-based Retinal Screening System Players by Revenue
3.1.1 Global Top AI-based Retinal Screening System Players by Revenue (2020-2025)
3.1.2 Global AI-based Retinal Screening System Revenue Market Share by Players (2020-2025)
3.2 Global Top AI-based Retinal Screening System Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-based Retinal Screening System Revenue
3.4 Global AI-based Retinal Screening System Market Concentration Ratio
3.4.1 Global AI-based Retinal Screening System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-based Retinal Screening System Revenue in 2024
3.5 Global Key Players of AI-based Retinal Screening System Head office and Area Served
3.6 Global Key Players of AI-based Retinal Screening System, Product and Application
3.7 Global Key Players of AI-based Retinal Screening System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 AI-based Retinal Screening System Breakdown Data by Type
4.1 Global AI-based Retinal Screening System Historic Market Size by Type (2020-2025)
4.2 Global AI-based Retinal Screening System Forecasted Market Size by Type (2026-2031)

5 AI-based Retinal Screening System Breakdown Data by Application
5.1 Global AI-based Retinal Screening System Historic Market Size by Application (2020-2025)
5.2 Global AI-based Retinal Screening System Forecasted Market Size by Application (2026-2031)

6 North America
6.1 North America AI-based Retinal Screening System Market Size (2020-2031)
6.2 North America AI-based Retinal Screening System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI-based Retinal Screening System Market Size by Country (2020-2025)
6.4 North America AI-based Retinal Screening System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe AI-based Retinal Screening System Market Size (2020-2031)
7.2 Europe AI-based Retinal Screening System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI-based Retinal Screening System Market Size by Country (2020-2025)
7.4 Europe AI-based Retinal Screening System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 Asia-Pacific
8.1 Asia-Pacific AI-based Retinal Screening System Market Size (2020-2031)
8.2 Asia-Pacific AI-based Retinal Screening System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI-based Retinal Screening System Market Size by Region (2020-2025)
8.4 Asia-Pacific AI-based Retinal Screening System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 Latin America
9.1 Latin America AI-based Retinal Screening System Market Size (2020-2031)
9.2 Latin America AI-based Retinal Screening System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI-based Retinal Screening System Market Size by Country (2020-2025)
9.4 Latin America AI-based Retinal Screening System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa AI-based Retinal Screening System Market Size (2020-2031)
10.2 Middle East & Africa AI-based Retinal Screening System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI-based Retinal Screening System Market Size by Country (2020-2025)
10.4 Middle East & Africa AI-based Retinal Screening System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 Sibionics Technology
11.1.1 Sibionics Technology Company Details
11.1.2 Sibionics Technology Business Overview
11.1.3 Sibionics Technology AI-based Retinal Screening System Introduction
11.1.4 Sibionics Technology Revenue in AI-based Retinal Screening System Business (2020-2025)
11.1.5 Sibionics Technology Recent Development
11.2 Google
11.2.1 Google Company Details
11.2.2 Google Business Overview
11.2.3 Google AI-based Retinal Screening System Introduction
11.2.4 Google Revenue in AI-based Retinal Screening System Business (2020-2025)
11.2.5 Google Recent Development
11.3 AEYE Health
11.3.1 AEYE Health Company Details
11.3.2 AEYE Health Business Overview
11.3.3 AEYE Health AI-based Retinal Screening System Introduction
11.3.4 AEYE Health Revenue in AI-based Retinal Screening System Business (2020-2025)
11.3.5 AEYE Health Recent Development
11.4 RetinaLyze
11.4.1 RetinaLyze Company Details
11.4.2 RetinaLyze Business Overview
11.4.3 RetinaLyze AI-based Retinal Screening System Introduction
11.4.4 RetinaLyze Revenue in AI-based Retinal Screening System Business (2020-2025)
11.4.5 RetinaLyze Recent Development
11.5 VUNO
11.5.1 VUNO Company Details
11.5.2 VUNO Business Overview
11.5.3 VUNO AI-based Retinal Screening System Introduction
11.5.4 VUNO Revenue in AI-based Retinal Screening System Business (2020-2025)
11.5.5 VUNO Recent Development
11.6 MedImaging Integrated Solutions
11.6.1 MedImaging Integrated Solutions Company Details
11.6.2 MedImaging Integrated Solutions Business Overview
11.6.3 MedImaging Integrated Solutions AI-based Retinal Screening System Introduction
11.6.4 MedImaging Integrated Solutions Revenue in AI-based Retinal Screening System Business (2020-2025)
11.6.5 MedImaging Integrated Solutions Recent Development
11.7 EyRIS (SELENA+)
11.7.1 EyRIS (SELENA+) Company Details
11.7.2 EyRIS (SELENA+) Business Overview
11.7.3 EyRIS (SELENA+) AI-based Retinal Screening System Introduction
11.7.4 EyRIS (SELENA+) Revenue in AI-based Retinal Screening System Business (2020-2025)
11.7.5 EyRIS (SELENA+) Recent Development
11.8 Acer Medical
11.8.1 Acer Medical Company Details
11.8.2 Acer Medical Business Overview
11.8.3 Acer Medical AI-based Retinal Screening System Introduction
11.8.4 Acer Medical Revenue in AI-based Retinal Screening System Business (2020-2025)
11.8.5 Acer Medical Recent Development
11.9 Airdoc
11.9.1 Airdoc Company Details
11.9.2 Airdoc Business Overview
11.9.3 Airdoc AI-based Retinal Screening System Introduction
11.9.4 Airdoc Revenue in AI-based Retinal Screening System Business (2020-2025)
11.9.5 Airdoc Recent Development
11.10 Digital Diagnostics
11.10.1 Digital Diagnostics Company Details
11.10.2 Digital Diagnostics Business Overview
11.10.3 Digital Diagnostics AI-based Retinal Screening System Introduction
11.10.4 Digital Diagnostics Revenue in AI-based Retinal Screening System Business (2020-2025)
11.10.5 Digital Diagnostics Recent Development
11.11 EyRIS Pte Ltd
11.11.1 EyRIS Pte Ltd Company Details
11.11.2 EyRIS Pte Ltd Business Overview
11.11.3 EyRIS Pte Ltd AI-based Retinal Screening System Introduction
11.11.4 EyRIS Pte Ltd Revenue in AI-based Retinal Screening System Business (2020-2025)
11.11.5 EyRIS Pte Ltd Recent Development
11.12 Synapxe Pte Ltd
11.12.1 Synapxe Pte Ltd Company Details
11.12.2 Synapxe Pte Ltd Business Overview
11.12.3 Synapxe Pte Ltd AI-based Retinal Screening System Introduction
11.12.4 Synapxe Pte Ltd Revenue in AI-based Retinal Screening System Business (2020-2025)
11.12.5 Synapxe Pte Ltd Recent Development
11.13 RETINA-AI Health
11.13.1 RETINA-AI Health Company Details
11.13.2 RETINA-AI Health Business Overview
11.13.3 RETINA-AI Health AI-based Retinal Screening System Introduction
11.13.4 RETINA-AI Health Revenue in AI-based Retinal Screening System Business (2020-2025)
11.13.5 RETINA-AI Health Recent Development
11.14 Topcon Healthcare Inc.
11.14.1 Topcon Healthcare Inc. Company Details
11.14.2 Topcon Healthcare Inc. Business Overview
11.14.3 Topcon Healthcare Inc. AI-based Retinal Screening System Introduction
11.14.4 Topcon Healthcare Inc. Revenue in AI-based Retinal Screening System Business (2020-2025)
11.14.5 Topcon Healthcare Inc. Recent Development
11.15 Revenio Group
11.15.1 Revenio Group Company Details
11.15.2 Revenio Group Business Overview
11.15.3 Revenio Group AI-based Retinal Screening System Introduction
11.15.4 Revenio Group Revenue in AI-based Retinal Screening System Business (2020-2025)
11.15.5 Revenio Group Recent Development
11.16 Toku Eyes
11.16.1 Toku Eyes Company Details
11.16.2 Toku Eyes Business Overview
11.16.3 Toku Eyes AI-based Retinal Screening System Introduction
11.16.4 Toku Eyes Revenue in AI-based Retinal Screening System Business (2020-2025)
11.16.5 Toku Eyes Recent Development
11.17 Mediwhale
11.17.1 Mediwhale Company Details
11.17.2 Mediwhale Business Overview
11.17.3 Mediwhale AI-based Retinal Screening System Introduction
11.17.4 Mediwhale Revenue in AI-based Retinal Screening System Business (2020-2025)
11.17.5 Mediwhale Recent Development
11.18 Vistel
11.18.1 Vistel Company Details
11.18.2 Vistel Business Overview
11.18.3 Vistel AI-based Retinal Screening System Introduction
11.18.4 Vistel Revenue in AI-based Retinal Screening System Business (2020-2025)
11.18.5 Vistel Recent Development
11.19 Advantech
11.19.1 Advantech Company Details
11.19.2 Advantech Business Overview
11.19.3 Advantech AI-based Retinal Screening System Introduction
11.19.4 Advantech Revenue in AI-based Retinal Screening System Business (2020-2025)
11.19.5 Advantech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.in
Tel: +91-8149736330
Email- ankit@qyresearch.com

This release was published on openPR.